These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 12759554)

  • 1. Decreased lymphocyte 3H-paroxetine binding in obsessive-compulsive disorder.
    Marazziti D; Baroni S; Masala I; Giannaccini G; Mungai F; Di Nasso E; Cassano GB
    Neuropsychobiology; 2003; 47(3):128-30. PubMed ID: 12759554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet [3H]paroxetine binding in patients with OCD-related disorders.
    Marazziti D; Dell'Osso L; Presta S; Pfanner C; Rossi A; Masala I; Baroni S; Giannaccini G; Lucacchini A; Cassano GB
    Psychiatry Res; 1999 Dec; 89(3):223-8. PubMed ID: 10708268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased platelet 3H-paroxetine binding in obsessive-compulsive patients.
    Marazziti D; Rossi A; Gemignani A; Giannaccini G; Pfanner C; Milanfranchi A; Presta S; Lucacchini A; Cassano GB
    Neuropsychobiology; 1996; 34(4):184-7. PubMed ID: 9121618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced serotonin transporter-availability in obsessive-compulsive disorder (OCD).
    Stengler-Wenzke K; Müller U; Angermeyer MC; Sabri O; Hesse S
    Eur Arch Psychiatry Clin Neurosci; 2004 Aug; 254(4):252-5. PubMed ID: 15309396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No correlation between aggression and platelet (3)H-paroxetine binding in obsessive-compulsive disorder patients.
    Marazziti D; Conti L; Pfanner C; Presta S; Rossi A; Gemignani A; Dell'Osso L; Cassano GB
    Neuropsychobiology; 2001; 43(3):117-22. PubMed ID: 11287787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Center stage for the serotonin transporter: a gain-of-function polymorphism in persons with obsessive-compulsive disorder.
    Torres GE; Caron MG
    Mol Pharmacol; 2003 Aug; 64(2):196-8. PubMed ID: 12869622
    [No Abstract]   [Full Text] [Related]  

  • 7. Serotonin transporter modulation in blood lymphocytes from patients with major depression.
    Lima L; Urbina M
    Cell Mol Neurobiol; 2002 Dec; 22(5-6):797-804. PubMed ID: 12585696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet serotonergic predictors of clinical improvement in obsessive compulsive disorder.
    Delorme R; Chabane N; Callebert J; Falissard B; Mouren-Siméoni MC; Rouillon F; Launay JM; Leboyer M
    J Clin Psychopharmacol; 2004 Feb; 24(1):18-23. PubMed ID: 14709942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased inhibitory activity of protein kinase C on the serotonin transporter in OCD.
    Marazziti D; Masala I; Rossi A; Hollander E; Presta S; Giannaccini G; Mazzoni MR; Dell'Osso L; Lucacchini A; Cassano GB
    Neuropsychobiology; 2000; 41(4):171-7. PubMed ID: 10828725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of [3H]paroxetine to platelets of depressed patients: seasonal differences and effects of diagnostic classification.
    D'Hondt P; Maes M; Leysen JE; Gommeren W; Scharpé S; Cosyns P
    J Affect Disord; 1994 Sep; 32(1):27-35. PubMed ID: 7798464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presence and characterization of the serotonin transporter in human resting lymphocytes.
    Marazziti D; Rossi A; Giannaccini G; Baroni S; Lucacchini A; Cassano GB
    Neuropsychopharmacology; 1998 Aug; 19(2):154-9. PubMed ID: 9629569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated brain serotonin transporter availability in patients with obsessive-compulsive disorder.
    Pogarell O; Hamann C; Pöpperl G; Juckel G; Choukèr M; Zaudig M; Riedel M; Möller HJ; Hegerl U; Tatsch K
    Biol Psychiatry; 2003 Dec; 54(12):1406-13. PubMed ID: 14675805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple dose pharmacokinetics of paroxetine in children and adolescents with major depressive disorder or obsessive-compulsive disorder.
    Findling RL; Nucci G; Piergies AA; Gomeni R; Bartolic EI; Fong R; Carpenter DJ; Leeder JS; Gaedigk A; Danoff TM
    Neuropsychopharmacology; 2006 Jun; 31(6):1274-85. PubMed ID: 16319918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lower 3H-paroxetine binding in cerebral cortex of suicide victims is partly due to fewer high affinity, non-transporter sites.
    Mann JJ; Henteleff RA; Lagattuta TF; Perper JA; Li S; Arango V
    J Neural Transm (Vienna); 1996; 103(11):1337-50. PubMed ID: 9013420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obsessive-Compulsive Disorder, 5-HTTLPR polymorphism and treatment response.
    Di Bella D; Erzegovesi S; Cavallini MC; Bellodi L
    Pharmacogenomics J; 2002; 2(3):176-81. PubMed ID: 12082589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced dopamine transporter density in psychotropic-naive patients with obsessive-compulsive disorder shown by [123I]{beta}-CIT SPECT.
    van der Wee NJ; Stevens H; Hardeman JA; Mandl RC; Denys DA; van Megen HJ; Kahn RS; Westenberg HM
    Am J Psychiatry; 2004 Dec; 161(12):2201-6. PubMed ID: 15569890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of [3H]paroxetine and [3H]cyanoimipramine for quantitative measurement of serotonin transporter sites in human brain.
    Gurevich EV; Joyce JN
    Neuropsychopharmacology; 1996 May; 14(5):309-23. PubMed ID: 8703300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonin transporter and seasonal variation in blood serotonin in families with obsessive-compulsive disorder.
    Hanna GL; Himle JA; Curtis GC; Koram DQ; Veenstra-VanderWeele J; Leventhal BL; Cook EH
    Neuropsychopharmacology; 1998 Feb; 18(2):102-11. PubMed ID: 9430134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alteration of the platelet serotonin transporter in romantic love.
    Marazziti D; Akiskal HS; Rossi A; Cassano GB
    Psychol Med; 1999 May; 29(3):741-5. PubMed ID: 10405096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonin, 5-hydroxyindoleacetic acid and serotonin transporter in blood peripheral lymphocytes of patients with generalized anxiety disorder.
    Hernández E; Lastra S; Urbina M; Carreira I; Lima L
    Int Immunopharmacol; 2002 Jun; 2(7):893-900. PubMed ID: 12188031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.